Target intelligence / Profile preview

Serotonin receptor subtype 4 (5-HT4 receptor)

Target
5-HT4 receptor
Molecular classification
G protein-coupled receptor, Receptor, Class A (Rhodopsin-like) GPCR
01

Overview

Serotonin receptor subtype 4 (5-HT4 receptor, HTR4) is a G protein-coupled receptor predominantly coupled to Gs proteins, leading to the stimulation of adenylyl cyclase and increased intracellular cAMP[4][6][7]. It is structurally defined by seven transmembrane domains typical of class A (rhodopsin-like) GPCRs and exists in several splice variants with tissue-dependent expression, especially in the gastrointestinal tract, heart, and brain[4]. The 5-HT4 receptor plays a crucial physiological role in facilitating gastrointestinal motility by enhancing neurotransmitter release in the enteric nervous system, as well as modulating cardiac contractility and certain neuronal functions related to memory and cognition[4][6][7]. Clinically, it serves as a therapeutic target for gastrointestinal disorders such as irritable bowel syndrome and chronic constipation, but its role in cardiac tissue raises safety concerns regarding arrhythmogenic risk for certain agonists (notably cisapride and tegaserod)[4].

Other names
5-hydroxytryptamine receptor 45-HT4RHTR4
02

Mechanism of action

Agonists enhance gastrointestinal peristalsis by stimulating cAMP production in enteric neurons Some antagonists block downstream cAMP signaling Agonists can enhance acetylcholine release in specific CNS and peripheral tissues

03

Biological functions

Signal transductionRegulation of gastrointestinal motilityModulation of cardiac functionModulation of neuronal signalingMemory and cognition modulation
04

Disease associations

Gastrointestinal motility disorders (e.g., irritable bowel syndrome)Cardiovascular diseaseCognitive disordersDepression
05

Safety considerations

Cardiovascular adverse events (notably arrhythmias or QT prolongation, especially with cisapride and tegaserod)Diarrhea and abdominal discomfortHeadachePotential neurological effects (e.g., CNS stimulation or mood changes)
06

Interacting drugs

Prucalopride

5 more in the full profile.

07

Biomarkers

5-HT4 receptor expression level (for GI disorders drug response)cAMP formation as a pharmacodynamic marker

Beyond the preview

Go deeper on Serotonin receptor subtype 4 (5-HT4 receptor).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Serotonin receptor subtype 4 (5-HT4 receptor).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call